Surgical or Medical Treatment of Breast Cancer Metastasis: A Multicentre Observational Study
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The liver represents the third most common site of breast cancer (BC) metastases behind the lymphatics and bone. The primary treatment for BCLM remains chemo-therapy and, more recently, targeted immunotherapy. The role of liver resection in BCLM remains controversial. The primary aim of the study is to compare the efficacy of liver resection vs. medical therapy alone in Breast Cancer Liver Metastasis (BCLM) patients.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Wiek powyżej 18 lat
- •Zaawansowany nowotwór wątroby
- •Zaawansowany nowotwór wątroby z przerzutami poza wątrobę
- •Dowolny poprzedni rodzaj leczenia
- •Zdolność do zrozumienia i podpisania zgody na uczestnictwo
✗ Disqualifies
- •Brak możliwości udzielenia świadomej zgody
- •Pacjent, który otrzymywał tylko opiekę wspierającą lub opiekę paliatywną
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- November 14, 2023
- Sex
- No restrictions
Locations (1)
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Rome, Italy
Trial contact
Amelia Mattia, MD
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/1/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.